Post‐transplantation diabetes mellitus (PTDM) is a major complication in kidney transplant recipients leading to reduced allograft and patient survival. Given the high prevalence of diabetes in Qatar, which is twice the global average, we were interested in determining the incidence of PTDM, identifying risk factors, and comparing clinical outcomes in kidney transplant recipients with and without diabetes. We retrospectively followed up 191 adult kidney allograft recipients transplanted between January 1, 2012, and December 31, 2016, for a median of 41 months. A total of 76 patients (40%) had pre‐existing diabetes. A total of 39 patients developed PTDM during follow‐up; they represent 34% of patients who did not have diabetes prior to transplantation. Two thirds of PTDM occurred within 3‐6 months post‐transplantation. Prediabetes before transplant [OR = 6.07 (1.24‐29.74), P = .026] older recipient's age at the time of transplantation [OR = 1.10 (1.00‐1.20), P = .039] and average fasting blood sugar during 3‐6 months post‐transplant [OR = 1.06 (1.01‐1.11), P = .010] were independently associated with PTDM. Patient and kidney allograft survival rates exceeded 97% in all groups. The incidence of PTDM in kidney transplant recipients living in Qatar is high. Older age and prediabetes are independent risk factors for developing PTDM.

Background: Proper pain management after modified radical mastectomy is crucial for improving postoperative outcomes, reducing tumor recurrence, enhancing anti-metastatic activity and achieving excellent patient`s satisfaction. Thoracic fascial planes (TFP) blocks are novel, and safe analgesia modalities to control postmastectomy pain. This study was designed to assess the efficacy and safety of intraoperative TFP blocks for providing postoperative analgesia after modified radical mastectomy.Methods: During the period from March 2020 to April 2021, 30 females (ages 25–67 years) were scheduled for elective MRM and selected randomly to one of two groups; group-A included 15 patients who underwent MRM and anesthetized with both general anesthesia and regional anesthesia (TFP blocks), group-B included 15 patients who underwent MRM and anesthetized with only general anesthesia.Results: The group-A had statistically significantly lower pain scores. The time of first rescue nalbuphine dose post-operatively was statistically significantly longer in group-A compared to group-B. The total 24h nalbuphine consumption and postoperative non-steroidal ketorolac requirements/48h were significantly lower in group-A compared to group-B. Satisfaction score in group-A was statistically significantly better than that in group-B.Conclusions: Intraoperative thoracic fascial planes blocks are simple, safe, and highly effective analgesic modalities after breast surgery.

Background: Aortobifemoral Bypass (ABFB) remains effective and durable treatment option for Aortoiliac Occlusive Disease (AIOD) and of cost-benefit in our country because of high cost of endovascular intervention. Aim of Study: To assess results of aortobifemoral bypass technique in the management of TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions in aortoiliac segment. Patients and Methods: This prospective study was conducted on 19 patients with symptomatic aortoiliac atherosclerotic TASC II C and D lesions. All patients were subjected to clinical evaluation, laboratory assessment, CT angiography scan, respiratory function tests and cardiac assessment by echo Doppler. Aortobifemoral bypass was performed for all patients who were divided into two groups A & B according to type of proximal anastmosis. Follow-up period was 30 months. Results: All patients passed uneventful intra-operative course without technical failure; midline incision was done in 12 patients (63.2%). Proximal anastomosis was end to side in group A (13 patients (68.4%)) and end to end in group B (6 patients (31.6%)). Mean operative time and PO hospital stay was longer in Group B: (4.6 ± 1.9 hours, range: 3.2-5.7) and (7.2 ± 2.9 days, range: 6-9 days) respectively. Graft patency was 100%, 94.7% and 89.4% at 12, 24 and 30 months respectively. Conclusions: Aortobifemoral bypass is still a good option in aortoiliac occlusive disease especially complex lesions; TASC II C and D lesions as it has long durability and can be tailored to appropriately selected patients. So ABFB is still valuable technique in the field of vascular surgery.